
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Manufacturing from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/manufacturing/topic/15575/</link>
        <description>Articles tagged with Manufacturing from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business briefs: Bayer, FDA, Ranbaxy</title>
          <description>Bayer&apos;s prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations</description>
          <link>http://www.mmm-online.com/business-briefs-bayer-fda-ranbaxy/article/293533/</link>
          <pubDate>Wed, 15 May 2013 19:13:18 GMT</pubDate>
          <itunes:summary>Bayer&apos;s prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Navidea deploying MSLs in launch of new diagnostic agent</title>
          <description>Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.</description>
          <link>http://www.mmm-online.com/navidea-deploying-msls-in-launch-of-new-diagnostic-agent/article/291661/</link>
          <pubDate>Thu, 02 May 2013 16:15:10 GMT</pubDate>
          <itunes:summary>Medical science liaisons will educate nuclear-medicine clinicians as part of the launch of a new Navidea diagnostic agent for use in breast and skin cancer.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Excedrin relaunch features Sparks, &quot;Thank yous&quot; from migraine sufferers</title>
          <description>Novartis is hyping its relaunch of Excedrin with a celebrity spokesperson, a migraine app and a survey of women migraine sufferers - along with print and out-of-home ads, radio promotions, direct mail and social media.</description>
          <link>http://www.mmm-online.com/excedrin-relaunch-features-sparks-thank-yous-from-migraine-sufferers/article/269461/</link>
          <pubDate>Wed, 21 Nov 2012 19:07:28 GMT</pubDate>
          <itunes:summary>Novartis is hyping its relaunch of Excedrin with a celebrity spokesperson, a migraine app and a survey of women migraine sufferers - along with print and out-of-home ads, radio promotions, direct mail and social media.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: Eli Lilly and Novartis</title>
          <description>Eli Lilly to add manufacturing capacity in Indianapolis, Novartis invests more in Singapore</description>
          <link>http://www.mmm-online.com/company-news-eli-lilly-and-novartis/article/266164/</link>
          <pubDate>Wed, 31 Oct 2012 14:56:49 GMT</pubDate>
          <itunes:summary>Eli Lilly to add manufacturing capacity in Indianapolis, Novartis invests more in Singapore</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Op/Ed: Meningitis crisis and the threat to pharma</title>
          <description>The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.</description>
          <link>http://www.mmm-online.com/oped-meningitis-crisis-and-the-threat-to-pharma/article/263094/</link>
          <pubDate>Wed, 10 Oct 2012 19:06:58 GMT</pubDate>
          <itunes:summary>The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: UBM Medica, Bristol-Myers Squibb</title>
          <description>UBM Medica adds a third iPad app, BMS expands in Puerto Rico.</description>
          <link>http://www.mmm-online.com/company-news-ubm-medica-bristol-myers-squibb/article/249837/</link>
          <pubDate>Wed, 11 Jul 2012 17:53:04 GMT</pubDate>
          <itunes:summary>UBM Medica adds a third iPad app, BMS expands in Puerto Rico.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Company news: GlaxoSmithKline, AstraZeneca, Nature Publishing</title>
          <description>GlaxoSmithKline is building its first new UK factory in almost 40 years, the firm said, spurring jobs while breaking new ground at some of its current locations.</description>
          <link>http://www.mmm-online.com/company-news-glaxosmithkline-astrazeneca-nature-publishing/article/233198/</link>
          <pubDate>Thu, 22 Mar 2012 15:52:20 GMT</pubDate>
          <itunes:summary>GlaxoSmithKline is building its first new UK factory in almost 40 years, the firm said, spurring jobs while breaking new ground at some of its current locations.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Sanofi braces for patent cliff impact</title>
          <description>Sanofi is girding itself for an ugly year, forecasting a 12%-15% drop in business earnings per share for 2012 as the company absorbs the loss of patent exclusivity on a stable of drugs that brought in more than €4 billion last year.</description>
          <link>http://www.mmm-online.com/sanofi-braces-for-patent-cliff-impact/article/227180/</link>
          <pubDate>Thu, 09 Feb 2012 21:51:21 GMT</pubDate>
          <itunes:summary>Sanofi is girding itself for an ugly year, forecasting a 12%-15% drop in business earnings per share for 2012 as the company absorbs the loss of patent exclusivity on a stable of drugs that brought in more than €4 billion last year.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>J&amp;J says no shakeup at McNeil Consumer Healthcare unit</title>
          <description>J&amp;J is pushing back hard against a Wall Street Journal article suggesting that a pair of retirements and a promotion are part of a corporate shakeup of its recall-plagued McNeil Consumer Healthcare division.</description>
          <link>http://www.mmm-online.com/jj-says-no-shakeup-at-mcneil-consumer-healthcare-unit/article/225876/</link>
          <pubDate>Wed, 01 Feb 2012 21:03:58 GMT</pubDate>
          <itunes:summary>J&amp;J is pushing back hard against a Wall Street Journal article suggesting that a pair of retirements and a promotion are part of a corporate shakeup of its recall-plagued McNeil Consumer Healthcare division.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  